Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board, Launches New Corporate and Medical Affairs Websites

By Staff
Wednesday, November 8, 2023 12:21 AM BOSTON—Ace Vision Group, Inc., a leading medical device company, announced the addition of Dr. Cathleen McCabe, Dr. James Katz, Dr. Ehsan Sadri, and Dr. Dagny Zhu to its medical advisory board.

Envision Research Institute Appoints Dr. Jeremy Barton to Advance Research in Mobile Telemedicine for Low Vision

By Staff
Wednesday, November 8, 2023 12:15 AM WICHITA, Kans.—The Gigi and Carl Allen Envision Research Institute (ERI) has announced Dr. Jeremy Barton as a new research Fellow. With a doctoral background in applied physics and extensive research contributions on human disease, Dr. Barton's expertise will be invaluable to ERI's research framework

OptoTech Names Steve Schneider as Director, Global Consumables

By Staff
Tuesday, November 7, 2023 12:15 AM GERMANTOWN, Wis.—OptoTech Technologies has announced Steve Schneider as a new addition to its team. He joins OptoTech as director of global consumables.

Visioneering Technologies Inc. Appoints Dr. Juan Carlos Aragón as New CEO and Executive Director

By Staff
Wednesday, August 30, 2023 12:24 AM ATLANTA—Visioneering Technologies, Inc. (ASX:VTI), a U.S.-based medical device company and producer of the NaturalVue Multifocal 1 Day contact lenses, announced the appointment of Dr. Juan Carlos Aragón as chief executive officer and executive director, effective Oct. 1, 2023. Dr. Aragón brings over 30 years of leadership in the vision care industry to VTI. His experience includes senior executive leadership positions in several large international vision care companies, and managing divisions for the Americas, Asia Pacific and Europe.

IOT Appoints Adam Winkelman VP of Photochromic Lens Sales in North America

By Staff
Monday, July 10, 2023 12:18 AM TORRENCE, Calif.—IOT has appointed Adam Winkelman as vice president of sales, to spearhead the development and expansion of its photochromic lens category in North America.

PECAA and VSP Vision Launch Vision Exam Rebate and New Private Practice Certification Courses

By Staff
Tuesday, June 27, 2023 12:27 AM BOCA RATON, Fla., and RANCHO CORDOVA, Calif.—Professional Eye Care Associates of America together with VSP Vision is announcing new programs aimed at addressing two of the great challenges facing independent eyecare professionals.

Mojo Vision Raises $22.4 Million for Development of High Performance Micro-LED Technology

By Staff
Friday, April 7, 2023 12:15 AM SARATOGA, Calif.—Mojo Vision, the high-performance micro-LED company, has announced a $22.4 million new Series A investment round to propel the development and commercialization of its micro-LED display technology.

Trish Shomion Named American Academy of Optometry CEO

By Staff
Friday, March 17, 2023 12:24 AM ORLANDO, Fla.—The American Academy of Optometry (AAO) announced today that Trish Shomion, CAE, has been appointed CEO. Prior to this role, Shomion was a senior advisor with Global Management Partners, LLC (GMP).

Shopko Optical Appoints Kirk Lauterback to Chief Experience Officer

By Staff
Friday, March 10, 2023 12:21 AM GREEN BAY, Wis.—Shopko Optical, a provider of eyecare services across the Midwest for more than 40 years, announced the appointment of Kirk Lauterback to the newly created role of chief experience officer.

Cognivue Names Neuroscientist Dr. James E. Galvin as Chief Scientific Officer

By Staff
Wednesday, March 8, 2023 12:15 AM ROCHESTER, N.Y.—Neuroscience company Cognivue Inc. has named neuroscientist Dr. James E. Galvin as its chief scientific officer. He is the founding director of the Comprehensive Center for Brain Health, professor of neurology, and professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine. Dr. Galvin will remain at the University of Miami while assuming his new role at Cognivue, where he has served on the company’s clinical advisory board since March 2022.

Harrow Names Mark Mannebach, PhD, RPh, Head of Regulatory Affairs and Pharmacovigilance

By Staff
Tuesday, March 7, 2023 12:18 AM NASHVILLE, Tenn—Harrow, a leading U.S. eyecare pharmaceutical company, announced the appointment of Mark Mannebach, PhD, RPh, as head of regulatory affairs and pharmacovigilance, responsible for overseeing and managing all regulatory related submissions and strategy related to the company’s portfolio of new and existing products.

EyeBio Appoints Industry Leaders to Executive Team

By Staff
Tuesday, March 7, 2023 12:15 AM LONDON and NEW YORK—Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to patients with sight-threatening eye diseases, announced several appointments to its executive team. The company also announced details on Restoret, the first asset in a diversified pipeline of multi-specific agonist antibodies. Restoret is a tri-specific Wnt agonist antibody designed to address medical needs in patients with back-of-the-eye diseases. “We founded EyeBio to capture scientific advances and translate them into effective treatments for patients with serious eye diseases,” said David Guyer, MD, co-founder, CEO, and president of EyeBio.

More Speakers Join VM Summit 'Insight, Unseen' Program on March 15 in NYC

By Staff
Monday, January 23, 2023 12:24 AM NEW YORK—Several new speakers are joining the program roster at the upcoming Vision Monday Leadership Summit, "Insight, Unseen: How Leaders Uncover, Design and Scale Innovations." The live, in-person event to be held in New York on Wednesday, March 15, 2023, will feature prominent voices and key opinion leaders in communications, business consulting, human resources, retailing and vision care. Their ideas will inform a daylong program designed for senior decision makers and influencers from throughout the optical industry and eyecare professions.

VM Leadership Summit ‘Insight, Unseen’ Announces First Speakers

By Staff
Thursday, January 19, 2023 12:30 AM NEW YORK—Organizers of the Vision Monday Leadership Summit announced the first speakers for the annual meeting, including business and health care experts who will offer insights about how leaders of companies and organizations can uncover, design and scale innovations. The VM Summit, a live, in-person event on Wednesday, March 15, 2023, will feature prominent voices and key opinion leaders in communications, business consulting, human resources, retailing and vision care. Their ideas will inform “Insight, Unseen,” a daylong program designed for senior decision makers and influencers from throughout the optical industry and eyecare professions.

Bausch + Lomb Amends CEO Separation Agreement With Joseph Papa

By Staff
Friday, December 30, 2022 12:21 AM VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO) (B+L) announced that the company and its CEO, Joseph C. Papa, have entered into an amended and restated separation agreement.